Diversified Trust Co Purchases 25 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Diversified Trust Co boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,383 shares of the medical equipment provider’s stock after purchasing an additional 25 shares during the quarter. Diversified Trust Co’s holdings in Intuitive Surgical were worth $2,288,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $37,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $38,000. Finally, DT Investment Partners LLC grew its position in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $531.88 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $324.12 and a 52-week high of $556.23. The stock has a market cap of $189.44 billion, a PE ratio of 85.51, a P/E/G ratio of 5.31 and a beta of 1.39. The firm has a 50-day moving average of $533.70 and a 200-day moving average of $492.90.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at $140,595. This represents a 88.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock worth $25,012,927 in the last ninety days. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.